Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:acute_myeloid_leukemia_subtype
|
| gptkbp:alsoKnownAs |
gptkb:acute_megakaryoblastic_leukemia
|
| gptkbp:associatedWith |
gptkb:Down_syndrome
|
| gptkbp:characterizedBy |
proliferation of megakaryoblasts
|
| gptkbp:class |
French-American-British (FAB) classification
|
| gptkbp:commonIn |
children
infants |
| gptkbp:diagnosedBy |
bone marrow biopsy
immunophenotyping flow cytometry |
| gptkbp:firstDescribed |
1980s
|
| gptkbp:ICD-10_code |
gptkb:C92.5
|
| gptkbp:marking |
gptkb:CD41
gptkb:CD42b gptkb:CD61 |
| gptkbp:prognosis |
variable
better in Down syndrome patients |
| gptkbp:treatment |
chemotherapy
hematopoietic stem cell transplantation |
| gptkbp:bfsParent |
gptkb:acute_megakaryoblastic_leukemia
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
AML M7
|